21 Jan 2021 NICE recommends Jyseleca® (filgotinib) on NHS in landmark decision for rheumatoid arthritis Member news
20 Jan 2021 Blue Matter announces acquisition of AIM, a leading European supply chain consulting firm Member news
14 Jan 2021 Bone Therapeutics and Rigenerand sign partnership for cell therapy process development Member news
12 Jan 2021 Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us